MIRA Pharmaceuticals Inc./$MIRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Ticker
$MIRA
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
-
Website
MIRA Metrics
BasicAdvanced
$30M
-
-$0.50
-
-
Price and volume
Market cap
$30M
52-week high
$2.09
52-week low
$0.73
Average daily volume
2.5M
Financial strength
Current ratio
12.855
Quick ratio
11.362
Profitability
Management effectiveness
Return on assets (TTM)
-193.30%
Return on equity (TTM)
-355.82%
Valuation
Price to book
21.44
Price to tangible book (TTM)
21.44
Price to free cash flow (TTM)
-4.275
Free cash flow yield (TTM)
-23.39%
Free cash flow per share (TTM)
-0.386
Growth
Earnings per share change (TTM)
-46.91%
3-year earnings per share growth (CAGR)
21.88%
MIRA News
AllArticlesVideos
MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
Accesswire·2 days ago
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain
Accesswire·3 days ago
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
Accesswire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MIRA Pharmaceuticals Inc. stock?
MIRA Pharmaceuticals Inc. (MIRA) has a market cap of $30M as of August 01, 2025.
What is the P/E ratio for MIRA Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for MIRA Pharmaceuticals Inc. (MIRA) stock is 0 as of August 01, 2025.
Does MIRA Pharmaceuticals Inc. stock pay dividends?
No, MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders as of August 01, 2025.
When is the next MIRA Pharmaceuticals Inc. dividend payment date?
MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders.
What is the beta indicator for MIRA Pharmaceuticals Inc.?
MIRA Pharmaceuticals Inc. (MIRA) does not currently have a Beta indicator.